associated

Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome

September 11, 2025 09:00 ET  | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows more than 50% reduction in photoreceptor loss caused…

5 days ago

Next Level Aviation Completes Recap of Turning Rock Partners

NLA completed the full redemption of Turning Rock's preferred equity investment ahead of schedule DANIA BEACH, Fla., Aug. 5, 2025 /PRNewswire/ -- Next Level Aviation® (NLA), a leader in…

1 month ago

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals…

3 months ago

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032

FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food…

3 months ago

Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them

Company announcement no. 7/2025 In accordance with Article 19 (3) of the Market Abuse Regulation, Columbus A/S is required to…

3 months ago